A randomised clinical trial of methadone vs. buprenorphine to opioid dependants;Buprenorfin og metadon til opiatavhengige - En randomisert studie

Tidsskrift for den Norske Laegeforening

Volumn 125, Issue 2, 2005, Pages 148-151

  Kristensen, Øistein ^a   Espegren, Olav ^a   Åsland, Reidun ^a   Jakobsen, Else ^a   Lie, Øystein ^a   Seiler, Stephen ^b  

^a Avd Rus og Avhengighetsbehandling   (Norway)

^b Institutt for Helse og Idrett   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CANNABIS; METHADONE; OPIATE; NARCOTIC AGENT;

ADULT; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRESS SYNDROME; DRUG EFFICACY; DRUG URINE LEVEL; FEMALE; HUMAN; MALE; NORWAY; OPIATE ADDICTION; RANDOMIZED CONTROLLED TRIAL; COMPARATIVE STUDY; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; BUPRENORPHINE; FEMALE; HUMANS; MALE; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 13744256673     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hermstad R, Johannessen G, Michelsen K. Hvilke effekter harvedlikeholdsbehandling med metadon på rehabilitering av heroinavhengige. Tidsskr Nor Lægeforen 1998; 118: 3139-41.
2. Bramness JG, Bachs LC, Waal H. Buprenorfin i legemiddelassistert rehabilitering av heroinavhengige. Tidsskr Nor Lægeforen 2002; 122: 2452-4.
3. Nutt DJ. Receptor pharmacology of buprenorphine. Res Clin Forums 1997; 19: 9-16.
4. Krook AL, Brørs O, Dahlberg J et al. A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitatation in Oslo, Norway. Addiction 2002; 97: 533-42.
5. Ling W, Wesson DR, Charuvastra C et al. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry 1996; 53: 401-7.
6. Eder H, Fischer G, Gombas W et al. Comparison of buprenorphine and methadone maintenance in opiate addicts. Eur Addict Res 1998; 4: 3-7.
7. Uehlinger C, Deglon J-J, Livoti S et al. Comparison of buprenorphine and methadone in the treatment of opioide dependence. Eur Addict Res 1998; 4: 13-8.
8. Johnson RE, Chutuape MA, Strain EC et al. A comparison of levomethadyl acetate, buprenorphine and methadone for opioid dependence. N Engl J Med 2000; 343: 1290-7.
9. Pani PP, Maremann I, Pirastu R et al. Buprenorphine: a controlled clinical trial in the treatment of opioid dependence. Drug Alcohol Depend 2000; 60: 39-50.
10. Petitjean S, Stohlen R, Deglon J-J et al. Double blind randomized trial of buprenorphine and methadone in opiate dependence. Drug Alcohol Depend 2001; 62: 97-104.
11. Derogatis LR. SCL-90-R. Administration, scoring and procedure manual. Baltimore: Clinical Psychometric Research, 1992.
12. Marsden J, Gossop M, Stewart D et al. The Maudsley addiction profile. A brief instrument for treatment outcome research. Development and user manual. London: National Addiction Centre, 1998.
13. Mattick NK, Kimber J, Breen C et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Library, 2003; 1: 1 -28.
14. Caplehorn JR, McNeil DR, Kleinbaum DG. Clinical policy and retention in methadone maintenance, Int J Addict 1993; 28: 73-89.
15. Mendelson J, Upton RA, Everhart ET et al. Bioavailability of sublingual buprenorphine. J Clin Pharmacol 1997; 37: 31-7.
16. Schuh KJ, Johanson CE. Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet. Drug Alcohol Depend 1999; 56: 55-60.